Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|December 14, 2004
Prediction of heart transplant rejection with a breath test for markers of oxidative stressMichael Phillips, John P Boehmer, Renee N Cataneo, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 8, 2014
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failureTuba Khawaja, Aalap Chokshi, Ruiping Ji, et al.
ESC Heart Failure|April 29, 2017
Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantationUlrike Schulze-Späte, Iman Mizani, Kristina Rodriguez Salaverry, et al.
The American Journal of Cardiology|October 7, 2021
Relation of Left Ventricular Assist Device Infections With Cardiac Transplant OutcomesAditya Parikh, Michael Halista, Samantha Raymond, et al.
Circulation|July 9, 2026
Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart AssociationJerome L Fleg, Jessica R Golbus, Jonathan Afilalo, et al.
Circulation|August 18, 2004
Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)Lynne Warner Stevenson, Leslie W Miller, Patrice Desvigne-Nickens, et al.
JACC. Heart Failure|July 30, 2021
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM StudyJuan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, et al.
Cardiovascular Drugs and Therapy|January 25, 2019
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?Carlos G Santos-Gallego, Alvaro Garcia-Ropero, Donna Mancini, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipientsHoward J Eisen, Jon Kobashigawa, Anne Keogh, et al.
The New England Journal of Medicine|September 1, 2007
Use of a continuous-flow device in patients awaiting heart transplantationLeslie W Miller, Francis D Pagani, Stuart D Russell, et al.
Pageof 15